Medical Appliances & Equipment

(ARAY) Accuray Presents Positive Data

Radiosurgery systems maker, Accuray Incorporated (ARAY) published encouraging data about its CyberKnife Robotic Radiosurgery System, which provides stereotactic body radiation therapy (SBRT) to treat prostrate cancer.

Clinical...

7Oct2013 | | Comments Off on (ARAY) Accuray Presents Positive Data | Continued

(STJ) St. Jude Medical Begins EnligHTNment Study

St. Jude Medical Inc. (STJ) commenced the EnligHTNment trial study at the EuroPCR to analyze the effectiveness of its EnligHTN Multi-Electrode Renal Denervation System in reducing major cardiovascular events such as strokes, heart...

15Sep2013 | | Comments Off on (STJ) St. Jude Medical Begins EnligHTNment Study | Continued

(EW) Edwards Lifesciences Sees Promising Data on Sapien XT

World’s leading provider of heart valves and hemodynamic monitoring Edwards Lifesciences Corporation (EW) disclosed positive one-year data on Edwards Sapien XT trans-catheter aortic heart valve from the post-approval study in Europe....

7Sep2013 | | Comments Off on (EW) Edwards Lifesciences Sees Promising Data on Sapien XT | Continued

(VOLC) Volcano Corporation Product Launch at EuroPCR

Recently, Volcano Corporation (VOLC) disclosed its plan to feature its innovative technologies, including the company’s Fractional Flow Reserve (FFR) and iFR (Instant Wave-Free Ratio) technologies at the EuroPCR 2013 in Paris.

At...

8Aug2013 | | Comments Off on (VOLC) Volcano Corporation Product Launch at EuroPCR | Continued

(STJ) St. Jude Medical Wins CE Mark for ILUMIEN OPTIS

Medical devices major, St. Jude Medical Inc. (STJ) has won CE Mark approval for its ILUMIEN OPTIS Percutaneous Coronary Intervention (PCI) Optimization System. This intravascular imaging technology is an advanced version of the company’s...

9Jul2013 | | Comments Off on (STJ) St. Jude Medical Wins CE Mark for ILUMIEN OPTIS | Continued

(STJ) St. Jude Medical Reiterated at Neutral

On May 9, we retained St. Jude Medical Inc. (STJ) at Neutral, following its first-quarter results. In spite of a declining top line due to difficult end-market pressures, the company was able to maintain its bottom-line growth.

Why...

23May2013 | | Comments Off on (STJ) St. Jude Medical Reiterated at Neutral | Continued

(STJ) St. Jude Medical’s New Quadra Study

St. Jude Medical (STJ) has enrolled the first patient for its MultiPoint Pacing clinical study. The study will evaluate the efficacy of the company’s Quadripolar Pacing system belonging to the implantable cardioverter defibrillator...

17May2013 | | Comments Off on (STJ) St. Jude Medical’s New Quadra Study | Continued

(VOLC) Volcano Corporation Stays Neutral

Recently, we have reaffirmed our Neutral recommendation on Volcano Corporation (VOLC). Although we are concerned about the company’s disappointing fourth quarter 2012 and conservative outlook for 2013, strong pipeline development...

2May2013 | | Comments Off on (VOLC) Volcano Corporation Stays Neutral | Continued

(STJ) Will St. Jude Beat Earnings this Quarter?

St. Jude Medical Inc. (STJ) is set to report its first-quarter 2013 results before the opening bell on Wednesday, Apr 17. Let us see how things are shaping up prior to the announcement.

In the last quarter, the medical device...

27Apr2013 | | Comments Off on (STJ) Will St. Jude Beat Earnings this Quarter? | Continued

(ISRG) Intuitive Surgical Earnings Preview

Intuitive Surgical (ISRG), the leader in robotic surgery, is set to report its first-quarter 2013 results on Apr 18, 2013. Let’s see how things are shaping up prior to the announcement.

In the last quarter, the company posted...

27Apr2013 | | Comments Off on (ISRG) Intuitive Surgical Earnings Preview | Continued

(CUTR) Biolase Gets U.S. Food & Drug Administration Nod for EPIC 10S

Recently, a pioneer in manufacturing and distributing dental lasers, BIOLASE, Inc. (BIOL) obtained regulatory clearance from the U.S. Food & Drug Administration (FDA) for its EPIC 10S soft tissue diode laser. Last month the company...

23Apr2013 | | Comments Off on (CUTR) Biolase Gets U.S. Food & Drug Administration Nod for EPIC 10S | Continued

(STJ) St. Jude Medical Begins EnligHTN II Trial

St. Jude Medical Inc. (STJ) has initiated the EnligHTN II trail with the enrolment of first patient to further evaluate its renal denervation technology in treating uncontrolled hypertension. This follows the successful EnligHTN I...

16Feb2013 | | Comments Off on (STJ) St. Jude Medical Begins EnligHTN II Trial | Continued

(VAR) Varian Medical Systems Receives FDA Clearance

Oncology and X-Ray products company Varian Medical Systems (VAR) recently revealed that it has received FDA 510(k) clearance for its Edge radiosurgery offering. This is Varian’s latest system for carrying out radiosurgery using modern...

29Jan2013 | | Comments Off on (VAR) Varian Medical Systems Receives FDA Clearance | Continued

(STJ) St. Jude Medical’s Products Earn CE Mark Approval

St. Jude Medical (STJ) has received CE Mark approval for two of its devices viz. the AMPLATZER Amulet Left Atrial Appendage Occluder and the ViewFlex Xtra Intracardiac Echocardiography (ICE) Catheter. Both the products were unveiled...

26Jan2013 | | Comments Off on (STJ) St. Jude Medical’s Products Earn CE Mark Approval | Continued

(VOLC) Volcano Presents Preliminary Fourth Quarter Results

Going by the preliminary results, Volcano Corporation (VOLC) expects to report revenues of $102.5 million for the fourth quarter of fiscal 2012, up 10% year over year (up 12% at constant exchange rate or CER). However, the result...

15Jan2013 | | Comments Off on (VOLC) Volcano Presents Preliminary Fourth Quarter Results | Continued

(MASI) Another Client Win for Masimo

Masimo Corporation (MASI), a leader in non-invasive monitoring technology, recently announced that the University of North Carolina (UNC) Hospitals in Chapel Hill have adopted Masimo SET pulse oximetry. This marks Masimo’s second...

1Jan2013 | | Comments Off on (MASI) Another Client Win for Masimo | Continued

(STJ) St. Jude Medical Wins CE Mark Approval for Assura

Medical devices major, St. Jude Medical (STJ) recently won the European CE Mark approval for its line of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators...

4Dec2012 | | Comments Off on (STJ) St. Jude Medical Wins CE Mark Approval for Assura | Continued

(SMA) Symmetry Medical’s Surgical Subsidiary Gains Ground in Italy

Symmetry Surgical, a subsidiary of orthopedic implants and instruments maker Symmetry Medical Inc. (SMA) recently inked an exclusive agreement in Italy with Biocommerciale Srl. Per the agreement, Biocomerciale...

4Dec2012 | | Comments Off on (SMA) Symmetry Medical’s Surgical Subsidiary Gains Ground in Italy | Continued

(ALGN) Align Technology’s Preliminary Third Quarter Sales Disappoint

A major player in the malocclusion market, Align Technology’s (ALGN) shares plunged 7.47% to close at $35.41 yesterday, following the release of its preliminary third quarter results that missed the Zacks Consensus Estimates on...

12Nov2012 | | Comments Off on (ALGN) Align Technology’s Preliminary Third Quarter Sales Disappoint | Continued

(ARAY) FDA Clears Accuray’s CyberKnife M6

Renowned radiosurgery systems maker, Accuray Incorporated (ARAY) recently received the U.S. Food and Drug Administration (“FDA”) 510(k) approval for its new Cybernife M6 Series. This innovative series is capable of treating large,...

6Nov2012 | | Comments Off on (ARAY) FDA Clears Accuray’s CyberKnife M6 | Continued

(STJ) St. Jude Medical Earnings Preview

Medical device major, St. Jude Medical (STJ) is slated to announce its third quarter results before the opening bell on Wednesday, October 17. The current Zacks Consensus Estimate for the third quarter is 80 cents, representing estimated...

31Oct2012 | | Comments Off on (STJ) St. Jude Medical Earnings Preview | Continued

(ISRG) Intuitive Surgical Earnings Preview

Intuitive Surgical (ISRG) is slated to report its third quarter results on Tuesday, October 16, 2012. The current Zacks Consensus Estimate for the third quarter is $3.48, representing an estimated 14.1% annualized growth.

First...

12Oct2012 | | Comments Off on (ISRG) Intuitive Surgical Earnings Preview | Continued

(CNMD) Conmed Lowered to Underperform

We downgrade our recommendation for Conmed Corporation (CNMD) to ‘Underperform’, driven by difficult hospital capital equipment spending environment and management’s lowered sales guidance outlook. Both revenues and earnings...

10Oct2012 | | Comments Off on (CNMD) Conmed Lowered to Underperform | Continued

(CNMD) Conmed Corporation – Bear of the Day

We downgrade our recommendation on Conmed Corporation (CNMD) to Underperform. Its earnings and revenues for the second quarter missed the Zacks Consensus Estimates. All business segments, except the Arthroscopy business, hampered...

9Oct2012 | | Comments Off on (CNMD) Conmed Corporation – Bear of the Day | Continued

(ALGN) Align Technology Speaks on Growth Prospects

Recently, Align Technology (ALGN) participated at the Morgan Stanley Healthcare Conference where the Vice President, Finance and Chief Financial Officer of Align, Kenneth Arola clearly spoke about the company’s key focus areas and...

8Oct2012 | | Comments Off on (ALGN) Align Technology Speaks on Growth Prospects | Continued

(CLSN) Celsion Progresses with ThermoDox

Celsion Corporation (CLSN) recently announced that the independent Data Monitoring Committee (DMC) completed its last intermediate review of the pivotal phase III HEAT study being conducted with ThermoDox for hepatocellular carcinoma...

8Oct2012 | | Comments Off on (CLSN) Celsion Progresses with ThermoDox | Continued

(STJ) St. Jude Medical Reports Positive Data

Medical devices major, St. Jude Medical, Inc. (STJ) recently announced results from a large-scale clinical study of peripheral nerve stimulus (PNS) of the occipital nerve for managing pain and disability associated with chronic migraine,...

8Oct2012 | | Comments Off on (STJ) St. Jude Medical Reports Positive Data | Continued

(SNN) MedTech Industry Stock Outlook – October 2012 – Zacks Analyst Interviews

The global medical devices industry is fairly large, intensely competitive and highly innovative. A regulated industry, MedTech is spread across different segments including cardiology, cardiovascular, neuro, orthopedic and aesthetic devices. The US medical devices industry relies largely on an aging...

4Oct2012 | | Comments Off on (SNN) MedTech Industry Stock Outlook – October 2012 – Zacks Analyst Interviews | Continued

(ALGN) Align Technology Incorporated – Bull of the Day

Align Technology, Inc. (ALGN) reported a strong second quarter with both revenues and earnings sailing past the Zacks Consensus Estimates, on the back of its flagship product, Invisalign. Growth was boosted by increased patient visits...

2Oct2012 | | Comments Off on (ALGN) Align Technology Incorporated – Bull of the Day | Continued

(STJ) St. Jude Medical Realigns Units – Cuts Jobs

Medical devices major, St. Jude Medical, Inc. (STJ) recently announced that it will consolidate its four operating segments into two units as a part of its cost-cutting measure to leverage future growth. The company also changed the...

18Sep2012 | | Comments Off on (STJ) St. Jude Medical Realigns Units – Cuts Jobs | Continued